Related Experiment Video
Updated: Dec 25, 2025

Tracking Hypoxic Signaling within Encapsulated Cell Aggregates
Published on: December 16, 2011
A hypoxia-activated antibacterial prodrug
Yuan Qi Yeoh1, John R Horsley1, Steven W Polyak2
1ARC Centre of Excellence for Nanoscale BioPhotonics (CNBP), Department of Chemistry, The University of Adelaide, North Terrace, Adelaide, SA 5005, Australia.
Abstract:
A prodrug based on a known antibacterial compound is reported to target Staphylococcus aureus and Escherichia coli under reductive conditions. The prodrug was prepared by masking the N-terminus and side chain amines of a component lysine residue as 4-nitrobenzyl carbamates. Activation to liberate the antibacterial was demonstrated on treatment with a model reductant, tin(II) chloride. The bioactivity of 1 was confirmed in antibacterial susceptibility assays whereas prodrug 2 was inactive.
Related Concept Videos
Hypoxia
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Prodrugs
Prodrugs help overcome...
Oxygen Requirements and Growth Patterns
Gene Regulation in Microbial Communities: Quorum Sensing
Oxygen Transport in the Blood
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...

